IDEXX Laboratories, Inc.
- Jurisdiction
United States - LEI
OGMTXK0LUU1HKV2P0J84 - ISIN
US45168D1046 (IDXX )- Sectors
Scores
- Fair value (Benjamin Graham formula)
-
€247.28 119.4% overvalued - Financial strength (Piotroski F-Value)
-
6
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
6
/ 7
Profile
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. Read full profile
Fundamentals
- Net revenue
€3.44B - Gross margin
61.5% - EBIT
€1.07B - EBIT margin
31.1% - Net income
€840.72M - Net margin
24.4%
Statement period: - (published )
Estimates
| Fiscal Year | Net revenue | Net income |
|---|---|---|
|
|
| |
|
|
| |
|
|
|
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
| Name | Title | Transaction Date | Shares | Price | Value |
|---|---|---|---|---|---|
| SZOSTAK M ANNE | N/A |
|
|
|
|
| Erickson Michael G | Executive Vice President |
|
|
|
|
| Hunt Nimrata | Executive Vice President |
|
|
|
|
| Underberg Sharon E. | EVP, GC & Corporate Secretary |
|
|
|
|
| Hunt Nimrata | Executive Vice President |
|
|
|
|
Congress transactions
| Name | Transaction date | Value |
|---|---|---|
| Byron Donalds | October 7, 2025 | $1.00K–$15.00K |
| Jefferson Shreve | June 22, 2025 | $100.00K–$250.00K |
| Robert Bresnahan | June 9, 2025 | $1.00K–$15.00K |
| Jefferson Shreve | May 8, 2025 | $50.00K–$100.00K |
| Robert Bresnahan | April 28, 2025 | $1.00K–$15.00K |
Investor transactions
| Name | Shares | Value | Last change | Change type |
|---|---|---|---|---|
| Terry Smith |
|
|
|
Sell |
| Ray Dalio |
|
|
|
Sell |